Neuromuscular Disease
RSSArticles
-
The Neurophysiological Features of Myoclonus-Dystonia
Myoclonus-dystonia is characterized by specific neurophysiological dysfunctions that appear to be different from the ones seen in other dystonias. -
Is Stem Cell Transplantation a Viable Treatment Option for CIDP?
In this small, uncontrolled trial, autologous stem cell transplantation appeared to be efficacious for the treatment of patients with refractory CIDP. -
Is Epilepsy Surgery on the Decline?
In this 20-year, retrospective study, the authors summarize surgical trends in three major German epilepsy centers and identified a declining prevalence of epilepsy surgery from 1998 to 2008. -
Atrial Fibrillation and Cryptogenic Stroke: Important New Information
Ischemic stroke remains a leading cause of death worldwide, and atrial fibrillation is a major risk factor, increasing the risk of ischemic stroke five-fold in those who have a confirmed diagnosis of atrial fibrillation. -
Neuropathy with Hepatitis C Virus-Related Cryoglobulinemia
Most patients who develop cryoglobulinemia associated with hepatitis C infection will develop symptoms and signs of a symmetric, distal sensory neuropathy. -
Trochlear Headache: A Rare, Specific 'Eye-strain' Headache
Trochlear headaches should be considered in patients with new onset, constant, unilateral eye pain, especially when the pain is aggravated by eye movement. -
Pesticides and Development of Alzheimer’s Disease — New Evidence
A new case-control study finds that increased levels of dichlorodiphenyldichloroethylene (DDE), which is the metabolite of the pesticide dichlorodiphenyltrichloroethane (DDT), are associated with an increased risk for Alzheimer's disease. -
MRI as a Biomarker for Hippocampal Injury in Febrile Status Epilepticus
In this prospective study, the authors use brain imaging criteria to determine whether acute febrile status results in acute hippocampal injury and potentially chronic hippocampal sclerosis. -
Stroke Alert: A Review of Current Clinical Stroke Literature
What is the Best Treatment for Cerebral Cavernous Malformations? -
Cerebrospinal Fluid ß-Amyloid 42 vs Amyloid PET Imaging in the Diagnosis of Alzheimer’s Disease
Aß 42, measured in cerebrospinal fluid, may help determine whether patients have normal or increased cortical Aß deposition. Additionally, abnormal PET 18F-flutemetamol retention levels correlate with disease stage in patients with mild cognitive symptoms.